Nabriva Therapeutics plc Operating Lease Liability
Nabriva Therapeutics plc had Operating Lease Liability of $168.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2021-03-11
- 2020-12-31: Operating Lease, Liability $168.00K.
- 2020-09-30: Operating Lease, Liability $1.45M.
- 2020-06-30: Operating Lease, Liability $1.50M.
- 2020-03-31: Operating Lease, Liability $1.62M.
| Period end | Operating Lease, Liability |
|---|---|
| 2020-12-31 | $168.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.45M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.50M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.62M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.71M 10-K · filed 2020-03-12 |
| 2019-09-30 | $1.79M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.87M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.98M 10-Q · filed 2019-05-10 |